Annual Total Long Term Liabilities
$122.43 M
+$61.31 M+100.31%
March 31, 2024
Summary
- As of February 24, 2025, RDY annual total long term liabilities is $122.43 million, with the most recent change of +$61.31 million (+100.31%) on March 31, 2024.
- During the last 3 years, RDY annual total long term liabilities has fallen by -$624.30 thousand (-0.51%).
- RDY annual total long term liabilities is now -80.41% below its all-time high of $624.85 million, reached on March 31, 2006.
Performance
RDY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$321.08 M
-$5.89 M-1.80%
December 31, 2024
Summary
- As of February 24, 2025, RDY quarterly total long term liabilities is $321.08 million, with the most recent change of -$5.89 million (-1.80%) on December 31, 2024.
- Over the past year, RDY quarterly long term liabilities has increased by +$184.62 million (+135.28%).
- RDY quarterly long term liabilities is now -50.16% below its all-time high of $644.25 million, reached on September 30, 2006.
Performance
RDY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RDY Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.3% | +135.3% |
| 3 y3 years | -0.5% | +193.9% |
| 5 y5 years | -66.7% | +193.9% |
RDY Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.5% | +100.3% | -1.8% | +472.2% |
| 5 y | 5-year | -66.7% | +108.0% | -1.8% | +472.2% |
| alltime | all time | -80.4% | +608.8% | -50.2% | +2005.5% |
Dr Reddys Laboratories Limited Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $321.08 M(-1.8%) |
| Sep 2024 | - | $326.97 M(+81.9%) |
| Jun 2024 | - | $179.71 M(+37.1%) |
| Mar 2024 | $122.43 M(+100.3%) | $131.05 M(-4.0%) |
| Dec 2023 | - | $136.46 M(+16.4%) |
| Sep 2023 | - | $117.21 M(+6.7%) |
| Jun 2023 | - | $109.83 M(+79.7%) |
| Mar 2023 | $61.12 M(-44.1%) | $61.12 M(+8.9%) |
| Dec 2022 | - | $56.11 M(-3.1%) |
| Sep 2022 | - | $57.90 M(-4.7%) |
| Jun 2022 | - | $60.77 M(-44.4%) |
| Mar 2022 | $109.26 M(-11.2%) | $109.26 M(-7.9%) |
| Dec 2021 | - | $118.62 M(+1.7%) |
| Sep 2021 | - | $116.65 M(+1.1%) |
| Jun 2021 | - | $115.43 M(-6.2%) |
| Mar 2021 | $123.05 M(+109.1%) | $123.05 M(-0.5%) |
| Dec 2020 | - | $123.61 M(-3.3%) |
| Sep 2020 | - | $127.83 M(+0.7%) |
| Jun 2020 | - | $126.88 M(+115.6%) |
| Mar 2020 | $58.86 M(-84.0%) | $58.86 M(-7.1%) |
| Dec 2019 | - | $63.33 M(-76.3%) |
| Sep 2019 | - | $267.58 M(-6.8%) |
| Jun 2019 | - | $287.01 M(-21.9%) |
| Mar 2019 | $367.61 M(-18.7%) | $367.61 M(-9.5%) |
| Dec 2018 | - | $406.13 M(-6.4%) |
| Sep 2018 | - | $434.11 M(-1.0%) |
| Jun 2018 | - | $438.63 M(-3.0%) |
| Mar 2018 | $452.38 M(+172.2%) | $452.38 M(-0.6%) |
| Dec 2017 | - | $455.28 M(-0.3%) |
| Sep 2017 | - | $456.54 M(+0.5%) |
| Jun 2017 | - | $454.32 M(+173.4%) |
| Mar 2017 | $166.18 M(-24.8%) | $166.18 M(+3.9%) |
| Dec 2016 | - | $159.96 M(-31.7%) |
| Sep 2016 | - | $234.33 M(+11.2%) |
| Jun 2016 | - | $210.65 M(-4.6%) |
| Mar 2016 | $220.90 M(-29.0%) | $220.90 M(-7.8%) |
| Dec 2015 | - | $239.59 M(+1.9%) |
| Sep 2015 | - | $235.09 M(-15.3%) |
| Jun 2015 | - | $277.54 M(-10.8%) |
| Mar 2015 | $311.25 M(-26.5%) | $311.25 M(-5.2%) |
| Dec 2014 | - | $328.19 M(-10.5%) |
| Sep 2014 | - | $366.72 M(-7.7%) |
| Jun 2014 | - | $397.45 M(-6.2%) |
| Mar 2014 | $423.75 M(+49.0%) | $423.75 M(-0.8%) |
| Dec 2013 | - | $427.05 M(-4.2%) |
| Sep 2013 | - | $445.67 M(+64.2%) |
| Jun 2013 | - | $271.46 M(-4.5%) |
| Mar 2013 | $284.39 M | $284.39 M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $370.28 M(-0.9%) |
| Sep 2012 | - | $373.69 M(+8.5%) |
| Jun 2012 | - | $344.43 M(-4.8%) |
| Mar 2012 | $361.62 M(+101.8%) | $361.62 M(+1.5%) |
| Dec 2011 | - | $356.40 M(+112.8%) |
| Sep 2011 | - | $167.44 M(-8.0%) |
| Jun 2011 | - | $182.07 M(+1.6%) |
| Mar 2011 | $179.20 M(-4.2%) | $179.20 M(+184.2%) |
| Dec 2010 | - | $63.06 M(-44.8%) |
| Sep 2010 | - | $114.30 M(-23.3%) |
| Jun 2010 | - | $149.11 M(-20.3%) |
| Mar 2010 | $187.08 M(-37.6%) | $187.08 M(-14.5%) |
| Dec 2009 | - | $218.87 M(-19.5%) |
| Sep 2009 | - | $271.80 M(-19.4%) |
| Jun 2009 | - | $337.30 M(+12.5%) |
| Mar 2009 | $299.78 M(-35.6%) | $299.78 M(-10.8%) |
| Dec 2008 | - | $336.13 M(-9.0%) |
| Sep 2008 | - | $369.55 M(-13.6%) |
| Jun 2008 | - | $427.88 M(-8.1%) |
| Mar 2008 | $465.77 M(-22.5%) | $465.77 M(+3.3%) |
| Dec 2007 | - | $450.78 M(-3.9%) |
| Sep 2007 | - | $469.32 M(-5.0%) |
| Jun 2007 | - | $494.27 M(-17.7%) |
| Mar 2007 | $600.74 M(-3.9%) | $600.74 M(+8.0%) |
| Dec 2006 | - | $556.30 M(-13.7%) |
| Sep 2006 | - | $644.25 M(+2.1%) |
| Jun 2006 | - | $630.72 M(+0.9%) |
| Mar 2006 | $624.85 M(+3517.4%) | $624.85 M(+2889.8%) |
| Dec 2005 | - | $20.90 M(+23.6%) |
| Sep 2005 | - | $16.90 M(-11.2%) |
| Jun 2005 | - | $19.04 M(+10.2%) |
| Mar 2005 | $17.27 M(-26.4%) | $17.27 M(+13.3%) |
| Dec 2004 | - | $15.25 M(-15.7%) |
| Sep 2004 | - | $18.10 M(+3.3%) |
| Jun 2004 | - | $17.51 M(-25.3%) |
| Mar 2004 | $23.46 M(-1.6%) | $23.46 M(-0.5%) |
| Dec 2003 | - | $23.57 M(-4.5%) |
| Sep 2003 | - | $24.69 M(+3.1%) |
| Jun 2003 | - | $23.94 M(+0.4%) |
| Mar 2003 | $23.84 M(+1.3%) | $23.84 M(-15.1%) |
| Dec 2002 | - | $28.09 M(+1.9%) |
| Sep 2002 | - | $27.55 M(-0.7%) |
| Jun 2002 | - | $27.74 M(+17.8%) |
| Mar 2002 | $23.54 M(-48.3%) | $23.54 M(-8.6%) |
| Dec 2001 | - | $25.76 M(+9.3%) |
| Sep 2001 | - | $23.57 M(+8.6%) |
| Jun 2001 | - | $21.70 M |
| Mar 2001 | $45.57 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual total long term liabilities?
- What is the all time high annual total long term liabilities for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual total long term liabilities year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly long term liabilities year-on-year change?
What is Dr Reddys Laboratories Limited annual total long term liabilities?
The current annual total long term liabilities of RDY is $122.43 M
What is the all time high annual total long term liabilities for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual total long term liabilities is $624.85 M
What is Dr Reddys Laboratories Limited annual total long term liabilities year-on-year change?
Over the past year, RDY annual total long term liabilities has changed by +$61.31 M (+100.31%)
What is Dr Reddys Laboratories Limited quarterly total long term liabilities?
The current quarterly long term liabilities of RDY is $321.08 M
What is the all time high quarterly long term liabilities for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly total long term liabilities is $644.25 M
What is Dr Reddys Laboratories Limited quarterly long term liabilities year-on-year change?
Over the past year, RDY quarterly total long term liabilities has changed by +$184.62 M (+135.28%)